Chandan Healthcare Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Guidance rank: #2 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Based on Chandan Healthcare Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for the half year ended 30th September 2026 is ₹10,660.84 lakhs, compared to the previous year ended 31st March 2026 figure of ₹15,664.79 lakhs (note: annual figure), indicatin. Quarterly EBITDA: ₹3,133.05 lakhs (Q2 FY27), up 17.92% YoY from ₹2,656.09 lakhs.
From Chandan Healthcare Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did Chandan Healthcare's revenue grow in the September 2026 quarter?
What happened to Chandan Healthcare's margins in Q2 FY27?
Quarterly EBITDA: ₹3,133.05 lakhs (Q2 FY27), up 17.92% YoY from ₹2,656.09 lakhs
Locked: what Chandan Healthcare Ltd said on margins
Also locked on this page: fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Chandan Healthcare planning?
- Funding capital expenditure for setting up a flagship diagnostic centre in Jankipuram, Lucknow, Uttar Pradesh.
- Amount: ₹3,281.58 lakhs allocated; ₹2,775.89 lakhs utilized till Sep 2026.
- Status: Partially utilised.
- Timeline: Utilisation expected till Sep 2026.
- Funding capital expenditure towards installation of plant & machinery in new premises, including civil, electric, and fabrication work.
- Referenced under both Jankipuram and other locations (Ashiyana, Lucknow and Ayodhya).
- Amounts for Ashiyana (₹710.11 lakhs) and Ayodhya (₹710.23 lakhs) fully utilised by Sep 2026.
- General corporate purposes and issue related expenses also funded:
2 more points from Chandan Healthcare Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Chandan Healthcare raising money or cutting debt?
The company raised funds through an Initial Public Offer (IPO) on 17th Feb 2025, amounting to Rs. 7,044.64…
Locked: what Chandan Healthcare Ltd said on fundraising
Also locked on this page: margins, order book
Free account, 30 seconds. No card needed.
How big is Chandan Healthcare's order book?
See what Chandan Healthcare Ltd said on order book & pipeline — free account, 30 seconds.
Chandan Healthcare Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹81 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Healthcare Services
Continue your research
What Chandan Healthca's management said in earlier quarters
Others in Healthcare Services this season
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Health X Platform (Q2 FY27)
Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year (Page 24). Key investor presentation takeaways from Health X Platform Ltd's Q2 FY27 investor
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- 2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Chandan Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Chandan Healthcare Ltd Q2 FY27 results?
Revenue from operations for the half year ended 30th September 2026 is ₹10,660.84 lakhs, compared to the previous year ended 31st March 2026 figure of ₹15,664.79 lakhs (note: annual figure), indicatin. Quarterly EBITDA: ₹3,133.05 lakhs (Q2 FY27), up 17.92% YoY from ₹2,656.09 lakhs.
What is Chandan Healthcare Ltd share price analysis?
Chandan Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 21.9 with a market cap of ₹576 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chandan Healthcare Ltd planning capital expenditure?
Funding capital expenditure for setting up a flagship diagnostic centre in Jankipuram, Lucknow, Uttar Pradesh.
Keep Chandan Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.